The firm missed analyst estimates for revenues and loss per share, citing a continued investment in its AlloSure NGS test for the wider-than-expected loss.
CMDL is usingGenestack's platform to evaluate the effectiveness of bone marrow transplants and plans to use it for other oncology tests as well.
The companies are combining GMSbiotech's proprietary microarray platform with soluble human leukocyte antigen proteins produced by Pure Protein.
An analysis of samples taken a year after kidney transplant identified overlapping gene expression signatures associated with acute and chronic rejection.
Tricare is the healthcare program for active and returned military service members and their families, and covers more than 9 million individuals.
The Dutch firm plans to develop a complete, CE-marked pipeline for NGS-base HLA typing, from DNA amplification to software analysis.
For the Dutch firm, the certifications mark the last step in acquiring the AlleleSEQR product line from Quest subsidiary Celera.
The test is based on the company's TruGraf technology, which analyzes gene expression profiles to detect molecular signatures of acute transplant rejection.
The array, developed in collaboration with the International Genetics and Translational Research in Transplantation Network, is the first for transplant genomics.
By scrutinizing more than 30,000 samples over dozens of studies, the team is exploring the genetics of transplantation complications.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.